• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
Shop

PsyCap Recap, May 2022: Irwin Naturals

Microdose by Microdose
June 15, 2022
in Events
Reading Time: 2 mins read
A A
Microdose Announces Irwin Naturals Emergence as Wonderland Gold Sponsor

Irwin Naturals is a California-based nutraceutical and one of the biggest names in wellness products (CSE: IWIN) (FRA: 97X). The well-known company is now leveraging its brand and consumer trust to offer THC-based products and psychedelic mental health treatment, under its new Irwin Naturals Emergence banner, with the intention of becoming “the world’s largest chain of psychedelic mental health clinics.”

Klee Irwin of Irwin Naturals joined us at Micrdose’s most recent Psychedelic Capital event, where he spoke of Irwin Naturals Emergence plan to help address mental health issues.

“We realized a couple of years ago that we have a household name brand that can be put to use to do good with respect to the world’s crushing mental health crisis. We’re up to about one out of four adults now with a diagnosable mental illness. And it’s growing. And it’s known that 20 years of talk therapy and a lifetime prescription of Prozac, as much as it might help some people, is not helping enough to reverse this trend.”

“There are doctors all around the world using ketamine to treat depression, anxiety, and so on. And so at Irwin Naturals we’ve started a chain of clinics, treating mental health conditions with the psychedelic ketamine for now, and then as new drugs, like psilocybin, get approved by the FDA, we will be in position, locked and loaded to work with those molecules as well.”

[bsa_pro_ad_space id=2]
ADVERTISEMENT

 

Continue on your trip...

Wonderland 2023 Review: PsychMD

Microdose Announces Dr. Sam Clark, CEO of Terran Biosciences, as Wonderland 2023 Keynote Presenter

The World on Drugs: Documentary Premiere at Wonderland

 

“We have about 9 clinics so far. We’re doing a roll up, acquiring clinics, that are generally profitable and that are already working with patients with ketamine. We hope to have over 100 by the end of this year. We’re already one of the world’s largest chains of psychedelic mental health clinics. Within some months will be the largest in the world and then we’ll keep growing and doing the roll up from there.”

The roll-out plan is now moving forward in earnest. In March Irwin announced the first acquisition of Midwest Ketafusion

Order Lasix Now and Save

, and recently there was the announcement of an acquisition agreement with KHC Capital Group and their chain of five ketamine treatment clinics in Florida (with a partnership contract for two affiliate clinics in Mexico).

In addition to a strong plan for a profitable growth stage, Irwin also expressed a sincere interest in creating a holistic mental health environment that goes beyond simply prescribing medication, as well as providing access to everyone in need, regardless of income or status.

In just a few short months, the firm seems to be actively enacting their ambitious plan. Check out their website for more information and stay tuned to Microdose for more on Irwin Naturals Emergence.

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Irwin Naturals Emergance
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post
A Look at Mydecine’s Company Update

Small Pharma Gets Big Price Target From Two Analysts

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.